Screener
Sarepta Therapeutics, Inc. SRPT Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $571,148 | $801,282 |
| Short-term investments | 217,341 | 138,368 |
| Accounts receivable, net | 376,824 | 398,233 |
| Inventory | 904,273 | 914,744 |
| Manufacturing-related deposits and prepaids | 48,454 | 113,455 |
| Other current assets | 105,784 | 171,856 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s short-term investments?
- Sarepta Therapeutics, Inc. (SRPT) reported short-term investments of $217.34M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s short-term investments changed year-over-year?
- Sarepta Therapeutics, Inc.'s short-term investments decreased by 24.9% year-over-year, from $289.54M to $217.34M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s short-term investments?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s short-term investments has grown at a -20.5% compound annual growth rate (CAGR), from $435.92M to $138.37M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Sarepta Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude